72 related articles for article (PubMed ID: 25074478)
1. Comparison of biochemical failure rates between permanent prostate brachytherapy and radical retropubic prostatectomy as a function of posttherapy PSA nadir plus 'X'.
Ahmed KA; Davis BJ; Mynderse LA; Slezak JM; Bergstralh EJ; Wilson TM; Choo CR
Radiat Oncol; 2014 Jul; 9():171. PubMed ID: 25074478
[TBL] [Abstract][Full Text] [Related]
2. The biochemical recurrence-free rate in patients who underwent prostate low-dose-rate brachytherapy, using two different definitions.
Tanaka N; Asakawa I; Katayama E; Hirayama A; Hasegawa M; Konishi N; Fujimoto K
Radiat Oncol; 2014 May; 9():107. PubMed ID: 24885896
[TBL] [Abstract][Full Text] [Related]
3. Outcome comparison of radical prostatectomy versus seed brachytherapy for clinically localized prostate cancer using two biochemical recurrence definitions.
Zhu XH; Zhang F; Liu ZN; He JD; Li ZA; Ma LL; Huang Y; Lu J
BMC Surg; 2023 Aug; 23(1):253. PubMed ID: 37635216
[TBL] [Abstract][Full Text] [Related]
4. The relationship of the intensity of posttreatment prostate-specific antigen surveillance and prostate cancer outcomes: results from a population-based cohort.
Nabhan M; Kim SP; Shah ND; Bagniewski SM; Shi Q; Karnes RJ; Weight CJ; Davis BJ; Kohli M; Tilburt JC
Mayo Clin Proc; 2012 Jun; 87(6):540-7. PubMed ID: 22677074
[TBL] [Abstract][Full Text] [Related]
5. Stromal expression of MiR-21 predicts biochemical failure in prostate cancer patients with Gleason score 6.
Melbø-Jørgensen C; Ness N; Andersen S; Valkov A; Dønnem T; Al-Saad S; Kiselev Y; Berg T; Nordby Y; Bremnes RM; Busund LT; Richardsen E
PLoS One; 2014; 9(11):e113039. PubMed ID: 25401698
[TBL] [Abstract][Full Text] [Related]
6. Brachytherapy for favorable prognostic prostate cancer in men up to 60 years of age: Long term follow-up.
Jacques J; Sahki N; Meknaci É; Eschwege P; Peiffert D; Demogeot N
Brachytherapy; 2024; 23(3):301-308. PubMed ID: 38480107
[TBL] [Abstract][Full Text] [Related]
7. Soluble CD105 is prognostic of disease recurrence in prostate cancer patients.
Placencio-Hickok VR; Madhav A; Kim S; Duong F; Angara B; Liu Z; Bhowmick NA
Endocr Relat Cancer; 2020 Jan; 27(1):1-9. PubMed ID: 31648185
[TBL] [Abstract][Full Text] [Related]
8. Disease mapping: Geographic differences in population rates of interventional treatment for prostate cancer in Australia.
Cameron JK; Chandrasiri U; Millar J; Aitken JF; Cramb S; Dunn J; Frydenberg M; Rashid P; Mengersen K; Chambers SK; Baade PD; Smith DP
PLoS One; 2023; 18(11):e0293954. PubMed ID: 37956143
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors of Biochemical Failure in Locally Advanced Carcinoma Prostate Treated With Definitive External Beam Radiotherapy and Androgen Deprivation Therapy: Experience From Tertiary Care Center in North India.
Sidhu M; Paul D; Sood S; Jain K; Singh J; Aggarwal R; Sood D
Cureus; 2021 Aug; 13(8):e16895. PubMed ID: 34513468
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of early stage prostate cancer treated with brachytherapy analysis after a mean follow-up of 7 years.
Yan W; Chen J; Zhou Y; Zhou Z; Mai Z; Ji Z; Li H; Zhang F
Springerplus; 2014; 3():357. PubMed ID: 25089248
[TBL] [Abstract][Full Text] [Related]
11. Long-term erectile function following permanent seed brachytherapy treatment for localized prostate cancer.
Ong WL; Hindson BR; Beaufort C; Pharoah P; Millar JL
Radiother Oncol; 2014 Jul; 112(1):72-6. PubMed ID: 25086852
[TBL] [Abstract][Full Text] [Related]
12. Pathologic fracture in patients with metastatic prostate cancer.
Gartrell BA; Saad F
Curr Opin Urol; 2014 Nov; 24(6):595-600. PubMed ID: 25166424
[TBL] [Abstract][Full Text] [Related]
13. Salvage lymph node dissection for prostate cancer nodal recurrence detected by 11C-choline positron emission tomography/computerized tomography.
Karnes RJ; Murphy CR; Bergstralh EJ; DiMonte G; Cheville JC; Lowe VJ; Mynderse LA; Kwon ED
J Urol; 2015 Jan; 193(1):111-6. PubMed ID: 25150640
[TBL] [Abstract][Full Text] [Related]
14. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial.
Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
Lancet Oncol; 2014 Sep; 15(10):1076-89. PubMed ID: 25130995
[TBL] [Abstract][Full Text] [Related]
15. Permanent prostate brachytherapy with or without supplemental external beam radiotherapy as practiced in Japan: outcomes of 1300 patients.
Yorozu A; Kuroiwa N; Takahashi A; Toya K; Saito S; Nishiyama T; Yagi Y; Tanaka T; Shiraishi Y; Ohashi T
Brachytherapy; 2015; 14(2):111-7. PubMed ID: 25127123
[TBL] [Abstract][Full Text] [Related]
16. Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancer.
Ziehr DR; Chen MH; Zhang D; Braccioforte MH; Moran BJ; Mahal BA; Hyatt AS; Basaria SS; Beard CJ; Beckman JA; Choueiri TK; D'Amico AV; Hoffman KE; Hu JC; Martin NE; Sweeney CJ; Trinh QD; Nguyen PL
BJU Int; 2015 Sep; 116(3):358-65. PubMed ID: 25124891
[TBL] [Abstract][Full Text] [Related]
17. Treatment of bone metastases in urologic malignancies.
Froehner M; Hölscher T; Hakenberg OW; Wirth MP
Urol Int; 2014; 93(3):249-56. PubMed ID: 25115989
[TBL] [Abstract][Full Text] [Related]
18. Role of androgen deprivation therapy in early salvage radiation among patients with prostate-specific antigen level of 0.5 or less.
Parekh A; Chen MH; Graham P; Mahal BA; Hirsch AE; Nakabayashi M; Evan C; Kantoff PW; Martin NE; Nguyen PL
Clin Genitourin Cancer; 2015 Feb; 13(1):e1-6. PubMed ID: 25103271
[TBL] [Abstract][Full Text] [Related]
19. High-dose-rate brachytherapy as monotherapy for prostate cancer.
Demanes DJ; Ghilezan MI
Brachytherapy; 2014; 13(6):529-41. PubMed ID: 25085454
[TBL] [Abstract][Full Text] [Related]
20. Patterns of failure after iodine-125 seed implantation for prostate cancer.
Lamb DS; Greig L; Russell GL; Nacey JN; Broome K; Studd R; Delahunt B; Iupati D; Jain M; Rooney C; Murray J; Lamb PJ; Bethwaite PB
Radiother Oncol; 2014 Jul; 112(1):68-71. PubMed ID: 25082097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
